CB-839 (Telaglenastat): Enhancing Cancer Metabolism Workflow
2026-08-02
CB-839 (Telaglenastat) unlocks precise control of glutamine metabolism in preclinical cancer models, enabling high-fidelity glutaminolysis inhibition and robust readouts for apoptosis and autophagy. This guide synthesizes breakthrough assay designs, experimental protocols, and troubleshooting strategies to empower translational research teams.
4-Hydroxytamoxifen: Technical Guidance for Cancer and Cardia
2026-08-01
4-Hydroxytamoxifen (SKU B6167) offers a high-purity, DMSO-soluble estrogen receptor modulator for research applications in breast and prostate cancer, apoptosis assays, and cardiac myocyte calcium handling studies. It is unsuitable for protocols requiring water or ethanol solubility and demands careful storage and preparation to ensure reproducible results.
Telmisartan: Angiotensin II Receptor Antagonist for Cardiac
2026-07-31
Telmisartan is a potent angiotensin II receptor antagonist widely used in hypertension and cardiovascular disease research. It selectively blocks AT1 receptors, inhibiting vasoconstriction and aldosterone secretion, and has been benchmarked in cardiac hypertrophy models. Its solubility and stability properties make it suitable for robust in vitro and in vivo experimental workflows.
Ozone Stimulates Macrophage Efferocytosis to Relieve Neuropa
2026-07-31
This study demonstrates that ozone therapy alleviates neuropathic pain by promoting macrophage efferocytosis through the AMPK/Gas6-MerTK/SOCS3 pathway. The findings provide mechanistic insight into apoptotic cell clearance and neuroinflammation, identifying new therapeutic targets for neuropathic pain.
Mifepristone (RU486): Molecular Pathways and Precision in On
2026-07-30
Explore Mifepristone (RU486) as a precision tool for dissecting progesterone receptor signaling and tumor suppression. This article offers advanced mechanistic insights and protocol guidance for cancer and reproductive biology, uniquely contextualized by recent nuclear receptor research.
Tariquidar (XR9576): Potent P-gp Inhibition in Drug Resistan
2026-07-30
Tariquidar (XR9576) is a high-affinity noncompetitive inhibitor of P-glycoprotein (P-gp), widely used to dissect ABC transporter-mediated drug resistance. Its nanomolar potency and selectivity enable robust modulation of chemoresistance in both conventional and high-viscosity tumor models.
Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera
2026-07-29
This study introduces a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors with strong in vitro and in vivo efficacy. By targeting metabolic pathways central to diabetes, allergy, and cancer, these compounds offer promising directions for the development of oral therapies for diverse metabolic diseases.
Palmitic acid (Hexadecanoic Acid): Protocol and Workflow Gui
2026-07-29
Palmitic acid (SKU N2456) offers a high-purity, well-characterized saturated long-chain fatty acid for studies involving lipid metabolism, metabolic disorder research, and protein palmitoylation. It is not suitable for aqueous protocols or for long-term storage in solution, requiring precise solvent use and workflow discipline to maintain reproducibility.
RITA (NSC 652287): Optimizing Tumor Xenograft and Apoptosis
2026-07-28
RITA (NSC 652287) offers precise MDM2-p53 inhibition, enabling selective cytotoxicity and robust p53 pathway activation in cancer biology. This article translates recent in vitro and in vivo findings into actionable workflows and troubleshooting guidance, maximizing the compound’s impact in apoptosis assays and tumor xenograft models.
Nocodazole: Optimizing Microtubule Polymerization Inhibition
2026-07-28
Nocodazole stands out as a reversible, high-precision microtubule polymerization inhibitor, enabling reproducible studies in cell cycle regulation and cytoskeletal dynamics. This article delivers actionable workflow enhancements, troubleshooting tips, and insight from cutting-edge research, guiding advanced applications from cancer research to metabolism-cytoskeleton crosstalk.
Tropifexor (LJN452): Uncovering FXR Agonist Roles in Liver F
2026-07-27
Explore how Tropifexor (LJN452), a potent FXR agonist, advances liver fibrosis and metabolic disease research by modulating bile acid and epithelial barrier dynamics. This article uniquely bridges translational FXR biology with recent mechanistic insights and practical assay considerations.
Cyclophilin A Is Essential for Cyclosporin A Immunosuppressi
2026-07-27
This study demonstrates that the immunosuppressive effects of Cyclosporin A (CsA) depend critically on Cyclophilin A (CypA) in murine models. Mice lacking CypA exhibit resistance to CsA-mediated T-cell inhibition, highlighting CypA as the principal intracellular target mediating calcineurin inhibition and downstream immune suppression.
Spatial Proteomics Reveals PD-L1 and IL-6 Crosstalk in PSC
2026-07-26
This study uses spatial proteomics and cell-cell cross-talk analysis to demonstrate a direct interaction between PD-L1 and IL-6 signaling in primary sclerosing cholangitis (PSC). The findings deepen understanding of immune regulation in PSC and highlight interlinked therapeutic targets within immune checkpoint and cytokine pathways.
740 Y-P: PI 3-Kinase Activator for Vesicular and Survival As
2026-07-25
740 Y-P stands out as a robust PI 3-kinase activator enabling precise PI3K/AKT pathway modulation for vesicular trafficking, neuronal survival, and apoptosis assays. Its high solubility in DMSO and proven reliability in cell-based workflows make it an essential tool for advanced cell signaling research.
SGI-1027 and Everolimus Synergy in Renal Cancer Cell Death
2026-07-24
This study uncovers a novel cytotoxic mechanism for the DNA methyltransferase inhibitor SGI-1027, demonstrating its unique induction of methuosis and its synergistic effects with everolimus in renal cell carcinoma. The findings provide mechanistic insight into overcoming everolimus resistance and highlight the therapeutic potential of combining epigenetic modulation with mTOR inhibition.
507 records 13/34 page Previous Next First page 上5页 1112131415 下5页 Last page